ESMO Symposium on Immuno-Oncology 2015

Oncology Meeting Resources

20 Nov - 21 Nov 2015, Lausanne, Switzerland

ESMO-Symposium-on-Immuno-Oncology-2015-square

There is a paradigm shift in the treatment of cancer with recent research demonstrating that the immune system has tremendous potential to destroy tumours. Is immuno-oncology the new era of cancer medicine? 

Abstracts, presentations and webcasts from the ESMO Symposium on Immuno-Oncology 2015 are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...mmuno-Oncology-2015/Welcome-to-the-Symposium

Date: 20 Nov 2015
Presenter: Rolf A. Stahel
Resources: Presentation, Webcast
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...-a-perspective-and-a-glimpse-into-the-future

Date: 20 Nov 2015
Presenter: Gordon Freeman
Resources: Presentation, Webcast
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...-blockade-capitalises-on-cancer-neo-antigens

Date: 20 Nov 2015
Presenter: Matthew Hellman
Resources: Presentation, Webcast
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...val-for-patients-across-several-tumour-types

Date: 20 Nov 2015
Presenter: David Feltquate
Resources: Presentation, Webcast
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...ession-and-tumour-outcomes-in-NSCLC-patients

Date: 20 Nov 2015
Presenter: Gregory Lubiniecki
Resources: Presentation, Webcast
Topics: Cancer Immunology and Immunotherapy, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...future-for-personalised-cancer-immunotherapy

Date: 20 Nov 2015
Presenter: William Grossman
Resources: Presentation, Webcast
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...ons-Opportunities-anchored-on-PD-L1-blockade

Date: 20 Nov 2015
Presenter: Ramy Ibrahim
Resources: Presentation, Webcast
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...gy-2015/Combinations-with-epigenetic-therapy

Date: 20 Nov 2015
Presenter: Michele Maio
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...head-and-neck-squamous-cell-carcinoma-HNSCCa

AimHNSCCa is frequently associated with HPV infection. Immunotherapy with plasmids encoding HPV16 and HPV18 E6/E7 antigens has been shown to generate robust immune responses in women with cervical dysplasia.

Date: 20 Nov 2015
Presenter: Zane Yang
Resources: Abstract
Topics: Cancer Immunology and Immunotherapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...iagnosed-A2-glioblastoma-Preliminary-results

AimImmunotherapy has proved to have solid ground in the field of gliomas, the identification of tumor associated peptides on glioblastoma cells has been the background work that led to a multipeptide vaccine of 9 HLA A2 restricted peptides.

Date: 20 Nov 2015
Presenter: Denis Migliorini
Resources: Abstract
Topics: Cancer Immunology and Immunotherapy, Central Nervous System Malignancies